Description
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
In 2018, the global CRISPR/Cas9 market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR/Cas9 development in United States, Europe and China.
The key players covered in this study
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3961808-global-crispr-cas9-market-size-status-and-forecast-2019-2025
Market segment by Type, the product can be split into
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market segment by Application, split into
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players.
To present the CRISPR/Cas9 development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Leave a Query @ https://www.wiseguyreports.com/enquiry/3961808-global-crispr-cas9-market-size-status-and-forecast-2019-2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CRISPR/Cas9 Market Size Growth Rate by Type (2014-2025)
1.4.2 Genome Editing
1.4.3 Genetic engineering
1.4.4 gRNA Database/Gene Librar
1.4.5 CRISPR Plasmid
1.4.6 Human Stem Cells
1.4.7 Genetically Modified Organisms/Crops
1.4.8 Cell Line Engineering
1.5 Market by Application
1.5.1 Global CRISPR/Cas9 Market Share by Application (2014-2025)
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Academic Institutes
1.5.5 Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 CRISPR/Cas9 Market Size
2.2 CRISPR/Cas9 Growth Trends by Regions
2.2.1 CRISPR/Cas9 Market Size by Regions (2014-2025)
2.2.2 CRISPR/Cas9 Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
…
12 International Players Profiles
12.1 Caribou Biosciences
12.1.1 Caribou Biosciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 CRISPR/Cas9 Introduction
12.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2014-2019)
12.1.5 Caribou Biosciences Recent Development
12.2 Integrated DNA Technologies (IDT)
12.2.1 Integrated DNA Technologies (IDT) Company Details
12.2.2 Company Description and Business Overview
12.2.3 CRISPR/Cas9 Introduction
12.2.4 Integrated DNA Technologies (IDT) Revenue in CRISPR/Cas9 Business (2014-2019)
12.2.5 Integrated DNA Technologies (IDT) Recent Development
12.3 CRISPR Therapeutics
12.3.1 CRISPR Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 CRISPR/Cas9 Introduction
12.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2014-2019)
12.3.5 CRISPR Therapeutics Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 CRISPR/Cas9 Introduction
12.4.4 Merck Revenue in CRISPR/Cas9 Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Mirus Bio
12.5.1 Mirus Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 CRISPR/Cas9 Introduction
12.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2014-2019)
12.5.5 Mirus Bio Recent Development
12.6 Editas Medicine
12.6.1 Editas Medicine Company Details
12.6.2 Company Description and Business Overview
12.6.3 CRISPR/Cas9 Introduction
12.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2014-2019)
12.6.5 Editas Medicine Recent Development
12.7 Takara Bio
12.7.1 Takara Bio Company Details
12.7.2 Company Description and Business Overview
12.7.3 CRISPR/Cas9 Introduction
12.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2014-2019)
12.7.5 Takara Bio Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Company Details
12.8.2 Company Description and Business Overview
12.8.3 CRISPR/Cas9 Introduction
12.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2014-2019)
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group Company Details
12.9.2 Company Description and Business Overview
12.9.3 CRISPR/Cas9 Introduction
12.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2014-2019)
12.9.5 Horizon Discovery Group Recent Development
12.10 Intellia Therapeutics
12.10.1 Intellia Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 CRISPR/Cas9 Introduction
12.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2014-2019)
12.10.5 Intellia Therapeutics Recent Development
12.11 Agilent Technologies
12.12 Cellecta
12.13 GenScript
12.14 GeneCopoeia
12.15 Synthego
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3961808
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3961808-global-crispr-cas9-market-size-status-and-forecast-2019-2025